Your missing my point
CSL moving into gene therapy tells you the core business is under threat.
I suggest you study the frequency of dose of CSL HAE v Takeda/Shire and the efficacy.
Then come back and tell me what do patient prefer.
CSL is ridiculously expensive.
its the most expensive Pharma company in the world !!!
The CSL pattern, page-266
-
- There are more pages in this discussion • 1,051 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$296.17 |
Change
-0.520(0.18%) |
Mkt cap ! $143.6B |
Open | High | Low | Value | Volume |
$296.70 | $297.28 | $295.09 | $55.07M | 185.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9 | $296.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$296.18 | 157 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 37 | 296.470 |
6 | 74 | 296.460 |
8 | 408 | 296.450 |
2 | 9 | 296.440 |
1 | 5 | 296.430 |
Price($) | Vol. | No. |
---|---|---|
296.500 | 49 | 5 |
296.520 | 16 | 1 |
296.530 | 59 | 1 |
296.540 | 28 | 2 |
296.550 | 206 | 4 |
Last trade - 15.06pm 17/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |